Skip to the beginning of the images gallery

β-Alanine - BioReagent, suitable for cell culture, suitable for insect cell culture, high purity , CAS No.107-95-9

13 Citations

BioReagent

Moligand™

for cell culture

for insect cell culture

CAS#: 107-95-9
Formula: C₃H₇NO₂
Molecular Weight: 89.09
Beilstein Registry Number: 906793
EC Number: 203-536-5
PubChem CID: 239

Item Number

A431363

Grouped product items
SKU	Size	Availability	Price	Qty
A431363-10mg	10mg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$110.90
A431363-100g	100g	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$111.90

Basic Description

Synonyms	beta-alanine \| 3-Aminopropanoic acid \| 107-95-9 \| 3-Aminopropionic acid \| Beta Alanine \| Abufene \| H-beta-Ala-OH \| beta-Aminopropionic acid \| 2-Carboxyethylamine \| .beta.-Alanine \| Alanine, beta- \| beta-Ala \| Propanoic acid, 3-amino- \| 3-Aminopropionsaeure \| beta-Aminopropionsaeure \|
Specifications & Purity	Moligand™, BioReagent, for cell culture, for insect cell culture
Biochemical and Physiological Mechanisms	β-Alanine, a β−amino acid, is a component of pantothenic acid and the rate-limiting amino acid in the biosynthesis of the histidinyl antioxidant dipeptides carnosine and anserine. Endogenous β-amino acid that is a nonselective agonist at glycine receptors
Grade	BioReagent, for cell culture, for insect cell culture, Moligand™
Product Description	An N-blocked form of alanine.

Associated Targets(Human)

MRGPRD Tchem Mas-related G-protein coupled receptor member D (3 Activities)

Discover Target: MRGPRD

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

SLC6A1 Tclin GABA transporter 1 (308 Activities)

Discover Target: SLC6A1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)

Discover Target: GRIN1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

SLC6A11 Tchem GABA transporter 3 (176 Activities)

Discover Target: SLC6A11

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)

Discover Target: CYP2D6

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)

Discover Target: CYP1A2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)

Discover Target: CYP2C9

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)

Discover Target: CYP2C19

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)

Discover Target: CYP3A4

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

RGS4 Tchem Regulator of G-protein signaling 4 (13867 Activities)

Discover Target: RGS4

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

SLC36A1 Tchem Proton-coupled amino acid transporter 1 (102 Activities)

Discover Target: SLC36A1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

SLC16A10 SLC16A10 protein (28 Activities)

Discover Target: SLC16A10

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Associated Targets(non-human)

Slc6a13 GABA transporter 2 (37 Activities)

Discover Target: Slc6a13

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Slc6a11 GABA transporter 4 (930 Activities)

Discover Target: Slc6a11

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

lef Anthrax lethal factor (7585 Activities)

Discover Target: lef

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

panC Pantothenate synthetase (234 Activities)

Discover Target: panC

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Names and Identifiers

IUPAC Name	3-aminopropanoic acid
INCHI	InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)
InChi Key	UCMIRNVEIXFBKS-UHFFFAOYSA-N
Canonical SMILES	C(CN)C(=O)O
Isomeric SMILES	C(CN)C(=O)O
WGK Germany	3
PubChem CID	239
Molecular Weight	89.09
Beilstein	906793
Reaxy-Rn	906793

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

Melt Point(°C)	205°C

Safety and Hazards(GHS)

WGK Germany	3
Reaxy-Rn	906793
Merck Index	205

FAQs and Articles

FAQ

Guidelines For Common Cell Culture Media

Categories: Technical articles

Tags:

Biological buffer Cell medium raw materials Cell culture additives Amino acids Vitamins Growth factors Salt Glucose Nucleosides & nucleotides Carbs Cell culture and transfection

Citations of This Product

1. Zelai Li, Maohong Fan, Ge Gao, Wufeng Jiang, Xiaoshan Li, Cong Luo, Liqi Zhang, Fan Wu. (2024) Potassium β–alanine – A promising agent for reducing carbon capture cost via electrochemically mediated amine regeneration. SEPARATION AND PURIFICATION TECHNOLOGY, 334 (125984). [PMID:]
2. Wei Hu, Jingchun Huang, Junwen Wang, Di Xie, Zhenqi Wang, Yu Qiao, Minghou Xu. (2024) Benign-by-design N-doped activated carbon from wasted aqueous assisted hydrochar of leftover rice for efficient H2S removal. FUEL, 358 (31): (130233). [PMID:10734105]
3. Ziyang Huang, Mingyang Guan, Ziting Bao, Fengyi Dong, Xiaolin Cui, Guozhen Liu. (2023) Ligand Mediation for Tunable and Oxide Suppressed Surface Gold-Decorated Liquid Metal Nanoparticles. Small, (2306652). [PMID:37806762]
4. Wenting Li, Hanjie Zhang, Sijie Huang, Jingyi Xu, Liping Liu, Junshan Li, Jianfang Jing, Yongfa Zhu. (2024) Electron-enriched supramolecular PDI-SiO2 promoting PDS activation for enhanced photocatalytic advanced oxidation. APPLIED CATALYSIS B-ENVIRONMENTAL, 340 (19): (123262). [PMID:17956732]
5. Rong Ji, Yuming Dong, Hui Zhao, Chengsi Pan, Guangli Wang, Yongfa Zhu, Junshan Li. (2023) Z-scheme cobalt-iron oxide/perylene diimide supermolecule heterojunction for high-efficiency ciprofloxacin removal in a photocatalysis-self-Fenton system. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 648 (623). [PMID:37321081]
6. Hui Xu, Chaohua Peng, Long Xia, Zhongxi Miao, Siyuan He, Cheng Chi, Weiang Luo, Guorong Chen, Birong Zeng, Shuchuan Wang, Lizong Dai. (2023) A Novel Anderson-Type POMs-Based Hybrids Flame Retardant for Reducing Smoke Release and Toxicity of Epoxy Resins. MACROMOLECULAR RAPID COMMUNICATIONS, 44 (17): (2300162). [PMID:37114515]
7. Kaiyang Shi, Man Zhou, Fulin Wang, Xiangwei Li, Weiya Huang, Kangqiang Lu, Kai Yang, Changlin Yu. (2023) Perylene diimide/iron phthalocyanine Z-scheme heterojunction with strong interfacial charge transfer through π-π interaction: Efficient photocatalytic degradation of tetracycline hydrochloride. CHEMOSPHERE, 329 (138617). [PMID:37037355]
8. Ziyang Lu, Bing Li, Xiaodie Zhu, Yangrui Xu, Jutao Zhang, Guosheng Zhou, Binghui Wei, Xinlin Liu, Jinyu Chu, Chundu Wu. (2023) IM-PDI/ZFO S-scheme heterojunction assembled by mutual magnetic attraction towards enhancing selective photodegradation ability. INORGANIC CHEMISTRY COMMUNICATIONS, 152 (110716). [PMID:]
9. Hai-Bin Qin, Jun-Ping Zhou, Bo Zhang, Zhi-Qiang Liu, Yu-Guo Zheng. (2022) Combing with redox regulation via quorum-sensing system and fermentation strategies for improving D-pantothenic acid production. PROCESS BIOCHEMISTRY, 121 (681). [PMID:]
10. Ge Gao, Xiaoshan Li, Wufeng Jiang, Zhenghong Zhao, Yongqing Xu, Fan Wu, Cong Luo, Liqi Zhang. (2022) Improved quasi-cycle capacity method based on microcalorimetry strategy for the fast screening of amino acid salt absorbents for CO2 capture. SEPARATION AND PURIFICATION TECHNOLOGY, 289 (120767). [PMID:]
11. Yangrui Xu, Xiaodie Zhu, Huan Yan, Panpan Wang, Minshan Song, Changchang Ma, Ziran Chen, Jinyu Chu, Xinlin Liu, Ziyang Lu. (2022) Hydrochloric acid-mediated synthesis of ZnFe2O4 small particle decorated one-dimensional Perylene Diimide S-scheme heterojunction with excellent photocatalytic ability. CHINESE JOURNAL OF CATALYSIS, 43 (1111). [PMID:]
12. Haoyi Wang, Ye Zhou, Jinnan Wang, Aimin Li, Philippe François-Xavier Corvini. (2022) BiOBr/ Bi4O5Br2/PDI constructed for visible-light degradation of endocrine disrupting chemicals: Synergistic effects of bi-heterojunction and oxygen evolution. CHEMICAL ENGINEERING JOURNAL, 433 (133622). [PMID:]
13. Wenlong Zhang, Jincheng Mao, Zhenfu Jia, Xiaojiang Yang, Peng Zhang, Xiaodong Su, Chengyu Zhou, Dan Bao, Wenbi Zeng. (2021) Design of a salt-tolerant Gemini viscoelastic surfactant and the study of construction of wormlike micelle structure in high-salinity aqueous environment. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 631 (127653). [PMID:]

References

1. Milasta S, Pediani J, Appelbe S, Trim S, Wyatt M, Cox P, Fidock M, Milligan G. (2006) Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD.. Mol Pharmacol, 69 (2): (479-91). [PMID:16282220]
2. Billups D et al.. (2013) Inducible presynaptic glutamine transport supports glutamatergic transmission at the calyx of held synapse.. J Neurosci, 33 (44): (17429-34). [PMID:24174676]
3. I M Karmanskiĭ. (1977-07-01) [Effect of pepsin on low density serum lipoproteins].. Voprosy meditsinskoi khimii, 23 ((4)): (530-534). [PMID:200005]
4. M C Malet-Martino,J Bernadou,R Martino,J P Armand. (1988-01-01) 19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans.. Drug metabolism and disposition: the biological fate of chemicals, 16 ((1)): (78-84). [PMID:2894959]
5. B Holm,D W Nilsen,P Kierulf,H C Godal. (1985-01-01) Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.. Thrombosis research, 37 ((1)): (165-176). [PMID:3983897]
6. Y Chen,T V Getchell,D L Sparks,M L Getchell. (1994-03-01) Cellular localization of carnosinase in the human nasal mucosa.. Acta oto-laryngologica, 114 ((2)): (193-198). [PMID:8203202]
7. S Sumi,K Kidouchi,S Ohba,Y Wada. (1995-10-20) Automated screening system for purine and pyrimidine metabolism disorders using high-performance liquid chromatography.. Journal of chromatography. B, Biomedical applications, 672 ((2)): (233-239). [PMID:8581129]
8. N Tamaki,S Sakata,K Matsuda. (2001-10-26) [Beta-alanine aminotransferases on pyrimidine catabolism].. Seikagaku. The Journal of Japanese Biochemical Society, 73 ((9)): (1151-1154). [PMID:11675999]
9. K M Gibson,D S M Schor,M Gupta,W S Guerand,H Senephansiri,T G Burlingame,H Bartels,B M Hogema,T Bottiglieri,W Froestl,O C Snead,M Grompe,C Jakobs. (2002-06-18) Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase.. Journal of neurochemistry, 81 ((1)): (71-79). [PMID:12067239]
10. André B P Van Kuilenburg,Alida E M Stroomer,Henk Van Lenthe,Nico G G M Abeling,Albert H Van Gennip. (2004-01-07) New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?. The Biochemical journal, 379 ((Pt 1)): (119-124). [PMID:14705962]
11. Mark G Jones,Elizabeth Cooper,Saira Amjad,C Stewart Goodwin,Jeffrey L Barron,Ronald A Chalmers. (2005-07-05) Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.. Clinica chimica acta; international journal of clinical chemistry, 361 ((1-2)): (150-158). [PMID:15992788]
12. Klaus Albertshofer,Andrew M Siwkowski,Edward V Wancewicz,Christine C Esau,Tanya Watanabe,Kenji C Nishihara,Garth A Kinberger,Leila Malik,Anne B Eldrup,Muthiah Manoharan,Richard S Geary,Brett P Monia,Eric E Swayze,Richard H Griffey,C Frank Bennett,Martin A Maier. (2005-10-14) Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid.. Journal of medicinal chemistry, 48 ((21)): (6741-6749). [PMID:16220989]
13. Arun Sreekumar,Laila M Poisson,Thekkelnaycke M Rajendiran,Amjad P Khan,Qi Cao,Jindan Yu,Bharathi Laxman,Rohit Mehra,Robert J Lonigro,Yong Li,Mukesh K Nyati,Aarif Ahsan,Shanker Kalyana-Sundaram,Bo Han,Xuhong Cao,Jaeman Byun,Gilbert S Omenn,Debashis Ghosh,Subramaniam Pennathur,Danny C Alexander,Alvin Berger,Jeffrey R Shuster,John T Wei,Sooryanarayana Varambally,Christopher Beecher,Arul M Chinnaiyan. (2009-02-13) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.. Nature, 457 ((7231)): (910-914). [PMID:19212411]
14. Robert B Campenot,Karen Lund,Sue-Ann Mok. (2009-12-17) Production of compartmented cultures of rat sympathetic neurons.. Nature protocols, 4 ((12)): (1869-1887). [PMID:20010935]
15. Craig Sale,Bryan Saunders,Roger C Harris. (2010-01-22) Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance.. Amino acids, 39 ((2)): (321-333). [PMID:20091069]
16. K E Tiedje,K Stevens,S Barnes,D F Weaver. (2010-06-15) Beta-alanine as a small molecule neurotransmitter.. Neurochemistry international, 57 ((3)): (177-188). [PMID:20540981]
17. Silke Hack,Babette Wörlein,Georg Höfner,Jörg Pabel,Klaus T Wanner. (2011-03-01) Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.. European journal of medicinal chemistry, 46 ((5)): (1483-1498). [PMID:21353350]
18. Hans F N Kvitvang,Trygve Andreassen,Tomas Adam,Silas G Villas-Bôas,Per Bruheim. (2011-03-11) Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids.. Analytical chemistry, 83 ((7)): (2705-2711). [PMID:21388201]
19. Julie Y Culbertson,Richard B Kreider,Mike Greenwood,Matthew Cooke. (2010-01-01) Effects of beta-alanine on muscle carnosine and exercise performance: a review of the current literature.. Nutrients, 2 ((1)): (75-98). [PMID:22253993]
20. John Caruso,Jessica Charles,Kayla Unruh,Rachel Giebel,Lexis Learmonth,William Potter. (2012-08-02) Ergogenic effects of β-alanine and carnosine: proposed future research to quantify their efficacy.. Nutrients, 4 ((7)): (585-601). [PMID:22852051]
21. Roger C Harris,Craig Sale. (2012-10-19) Beta-alanine supplementation in high-intensity exercise.. Medicine and sport science, 59 (1-17). [PMID:23075550]
22. Wilson I Gonsalves,Rajiv K Pruthi,Mrinal M Patnaik. (2013-05-04) The new oral anticoagulants in clinical practice.. Mayo Clinic proceedings, 88 ((5)): (495-511). [PMID:23639500]
23. Carolyn M Millar,David A Lane. (2013-05-04) Blocking direct inhibitor bleeding.. Blood, 121 ((18)): (3543-3544). [PMID:23640994]
24. Jeff S Healey,John Eikelboom,Sean Yang,Ellison Themeles,Stuart J Connolly,Salim Yusuf,James Douketis,Lars Wallentin,Jonas Oldgren,Hein Heidbuchel,Alvaro Avezum,Paul Reilly,Michael Ezekowitz. (2013-05-07) Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.. Circulation, 127 ((11)): (e506-e506). [PMID:23646374]
25. Sushil Allen Luis,Karl Poon,Chris Luis,Akhil Shukla,Nicholas Bett,Christian Hamilton-Craig. (2013-05-23) Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.. Circulation. Cardiovascular imaging, 6 ((3)): (491-492). [PMID:23696587]
26. Dirk Einecke. (2013-05-25) [Venous thromboembolism. Currently it is worthwhile to use anticoagulants longer].. MMW Fortschritte der Medizin, 155 ((6)): (26-27). [PMID:23700693]
27. Kenneth A Bauer. (2013-06-05) Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.. Stroke, 44 ((6 Suppl 1)): (S38-S40). [PMID:23709725]
28. H H Klein. (2013-06-06) [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].. Deutsche medizinische Wochenschrift (1946), 138 ((24)): (1309-1311). [PMID:23737116]
29. Sam Schulman. (2013-06-14) Extended anticoagulation in venous thromboembolism.. The New England journal of medicine, 368 ((24)): (2329-2329). [PMID:23758240]
30. Andrew J Franck,Jessica A Bovio. (2013-06-14) Extended anticoagulation in venous thromboembolism.. The New England journal of medicine, 368 ((24)): (2328-2329). [PMID:23758241]
31. Hannes Neuwirt,Andreas Kronbichler. (2013-06-19) Dabigatran pharmacokinetics--implications for treatment.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 62 ((1)): (180-180). [PMID:23773843]
32. Robert G Hart,John W Eikelboom,K Scott Brimble,M Sean McMurtry,Alistair J Ingram. (2013-06-29) Stroke prevention in atrial fibrillation patients with chronic kidney disease.. The Canadian journal of cardiology, 29 ((7 Suppl)): (S71-S78). [PMID:23790601]
33. Doug Coyle,Kathryn Coyle,Chris Cameron,Karen Lee,Shannon Kelly,Sabine Steiner,George A Wells. (2013-06-26) Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16 ((4)): (498-506). [PMID:23796283]
34. Jecko Thachil,Gill Pike,Lynne Keighley-Jones,Michael J Nash. (2013-06-27) Plasma dabigatran activity one week after discontinuation despite normal renal function.. The American journal of medicine, 126 ((8)): (e5-e6). [PMID:23800582]
35. Adriano A Truffa,Renato D Lopes,L Kristin Newby. (2013-07-03) Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.. Postgraduate medicine, 125 ((2)): (146-157). [PMID:23816780]
36. . (2013-07-20) Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.. Prescrire international, 22 ((139)): (155-159). [PMID:23866358]
37. Roger C Harris,Trent Stellingwerff. (2013-08-01) Effect of β-alanine supplementation on high-intensity exercise performance.. Nestle Nutrition Institute workshop series, 76 (61-71). [PMID:23899755]
38. Jay Shavadia,Robert C Welsh. (2013-09-12) Acute management of ST-elevation myocardial infarction patients taking dabigatran.. The Canadian journal of cardiology, 29 ((11)): (1531-1531). [PMID:24021476]
39. Ramin Artang,Eric Rome,Jørn Dalsgaard Nielsen,Humberto J Vidaillet. (2013-10-01) Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors.. The American journal of cardiology, 112 ((12)): (1973-1979). [PMID:24075284]
40. Ammar Majeed,Hun-Gyu Hwang,Stuart J Connolly,John W Eikelboom,Michael D Ezekowitz,Lars Wallentin,Martina Brueckmann,Mandy Fraessdorf,Salim Yusuf,Sam Schulman. (2013-10-02) Management and outcomes of major bleeding during treatment with dabigatran or warfarin.. Circulation, 128 ((21)): (2325-2332). [PMID:24081972]
41. Waleed Ghanima,Dan Atar,Per Morten Sandset. (2013-10-03) New oral anticoagulants--a review.. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 133 ((18)): (1940-1945). [PMID:24084970]
42. Wayne L Chandler. (2013-10-15) Anticoagulation without monitoring.. American journal of clinical pathology, 140 ((5)): (606-607). [PMID:24124137]
43. Christina L Cove,Elaine M Hylek. (2013-10-25) An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.. Journal of the American Heart Association, 2 ((5)): (e000136-e000136). [PMID:24152980]
44. Su Emmanuelle Degirmenci,Annick Steib. (2013-10-31) [New direct oral anticoagulants and venous thromboprophylaxis].. La Revue du praticien, 63 ((7)): (976-979). [PMID:24167901]
45. Zachary D Goldberger,G Caleb Alexander. (2013-11-13) Digitalis use in contemporary clinical practice: refitting the foxglove.. JAMA internal medicine, 174 ((1)): (151-154). [PMID:24217624]
46. Wilma Potze,Freeha Arshad,Jelle Adelmeijer,Hans Blokzijl,Arie P van den Berg,Robert J Porte,Ton Lisman. (2013-11-14) Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.. British journal of haematology, 163 ((5)): (666-673). [PMID:24219333]
47. H T Benzon,M J Avram,D Green,R O Bonow. (2013-12-18) New oral anticoagulants and regional anaesthesia.. British journal of anaesthesia, 111 Suppl 1 (i96-113). [PMID:24335403]
48. B V Bloch,V Patel,A J Best. (2014-01-08) Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.. The bone & joint journal, 96-B ((1)): (122-126). [PMID:24395322]
49. Robert Gosselin,Emily Hawes,Stephan Moll,Dorothy Adcock. (2014-01-18) Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levels.. American journal of clinical pathology, 141 ((2)): (262-267). [PMID:24436275]
50. John W Eikelboom,Martina Brueckmann,Frans Van de Werf. (2014-01-24) Dabigatran in patients with mechanical heart valves.. The New England journal of medicine, 370 ((4)): (383-384). [PMID:24450899]
51. Alexander Speirs,Adam Deakin. (2014-01-24) Dabigatran in patients with mechanical heart valves.. The New England journal of medicine, 370 ((4)): (382-382). [PMID:24450902]
52. Torben Bjerregaard Larsen,Anders Gorst-Rasmussen,Lars Hvilsted Rasmussen,Flemming Skjøth,Mary Rosenzweig,Gregory Y H Lip. (2014-02-18) Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.. The American journal of medicine, 127 ((7)): (650-656). [PMID:24530792]
53. Alicia Molinier,Blandine Acket,Robert Bourrel,Orso Lavezzi,Jean-Louis Montastruc,Haleh Bagheri. (2014-02-19) [Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use].. Presse medicale (Paris, France : 1983), 43 ((4 Pt 1)): (468-469). [PMID:24534477]
54. Ajay Yadlapati,Christopher Groh,Rod Passman. (2014-03-01) Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.. The American journal of cardiology, 113 ((8)): (1362-1363). [PMID:24576547]
55. Henna Wong,David Keeling. (2014-03-13) Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.. British journal of haematology, 166 ((1)): (152-153). [PMID:24617554]
56. Stuart E Lind,Mary Ellen Boyle,Sheila Fisher,Jan Ishimoto,Toby C Trujillo,Tyree H Kiser. (2014-04-10) Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.. American journal of clinical pathology, 141 ((5)): (665-674). [PMID:24713737]
57. Jecko Thachil. (2014-04-10) The newer direct oral anticoagulants: a practical guide.. Clinical medicine (London, England), 14 ((2)): (165-175). [PMID:24715128]
58. Benjamin A Steinberg,Jonathan P Piccini. (2014-04-16) Anticoagulation in atrial fibrillation.. BMJ (Clinical research ed.), 348 (g2116-g2116). [PMID:24733535]
59. W L Baker,K W Chamberlin. (2014-06-20) New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?. Clinical pharmacology and therapeutics, 96 ((1)): (17-19). [PMID:24942397]
60. Khine Win,George M Rodgers. (2014-07-22) New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.. American journal of hematology, 89 ((10)): (1017-1017). [PMID:25043836]
61. Deborah Cohen. (2014-07-25) Dabigatran: how the drug company withheld important analyses.. BMJ (Clinical research ed.), 349 (g4670-g4670). [PMID:25055829]
62. Blake Charlton,Rita Redberg. (2014-07-25) The trouble with dabigatran.. BMJ (Clinical research ed.), 349 (g4681-g4681). [PMID:25055830]
63. Deborah Cohen. (2014-07-25) Concerns over data in key dabigatran trial.. BMJ (Clinical research ed.), 349 (g4747-g4747). [PMID:25055831]
64. Thomas J Moore,Michael R Cohen,Donald R Mattison. (2014-07-25) Dabigatran, bleeding, and the regulators.. BMJ (Clinical research ed.), 349 (g4517-g4517). [PMID:25056265]
65. Dorothea Baumann,Michael Haap,Christos Tsaousidis,Bernhard Krämer,Jürgen Schreieck,Karl Jaschonek,Ingo Rettig,Andreas Peter,Diethelm Wallwiener,Ferruh Artunc. (2014-07-30) [Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].. Deutsche medizinische Wochenschrift (1946), 139 ((30)): (1539-1539). [PMID:25072863]
66. Adam J McShane,Yuanyuan Shen,Mary Joan Castillo,Xudong Yao. (2014-08-06) Peptide dimethylation: fragmentation control via distancing the dimethylamino group.. Journal of the American Society for Mass Spectrometry, 25 ((10)): (1694-1704). [PMID:25091822]
67. Torben Bjerregaard Larsen,Lars Hvilsted Rasmussen,Anders Gorst-Rasmussen,Flemming Skjøth,Deirdre A Lane,Gregory Y H Lip. (2014-09-07) Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.. The American journal of medicine, 127 ((12)): (1172-1178). [PMID:25193361]
68. Stuart J Connolly,Lars Wallentin,Salim Yusuf. (2014-09-25) Additional events in the RE-LY trial.. The New England journal of medicine, 371 ((15)): (1464-1465). [PMID:25251519]
69. Stephan Kadauke,Bernard Khor,Elizabeth M Van Cott. (2014-10-09) Activated protein C resistance testing for factor V Leiden.. American journal of hematology, 89 ((12)): (1147-1150). [PMID:25293789]
70. David J Graham,Marsha E Reichman,Michael Wernecke,Rongmei Zhang,Mary Ross Southworth,Mark Levenson,Ting-Chang Sheu,Katrina Mott,Margie R Goulding,Monika Houstoun,Thomas E MaCurdy,Chris Worrall,Jeffrey A Kelman. (2014-11-02) Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.. Circulation, 131 ((2)): (157-164). [PMID:25359164]
71. Rita F Redberg. (2014-11-05) The importance of postapproval data for dabigatran.. JAMA internal medicine, 175 ((1)): (25-25). [PMID:25365377]
72. Inmaculada Hernandez,Seo Hyon Baik,Antonio Piñera,Yuting Zhang. (2014-11-05) Risk of bleeding with dabigatran in atrial fibrillation.. JAMA internal medicine, 175 ((1)): (18-24). [PMID:25365537]
73. J Beyer-Westendorf. (2014-11-08) [Bleeding complications under oral anticoagulation].. Deutsche medizinische Wochenschrift (1946), 139 ((49)): (2491-2493). [PMID:25376450]
74. Estella M Davis,Erin M Uhlmeyer,David P Schmidt,Greg L Schardt. (2014-12-09) Strategies for urgent reversal of target-specific oral anticoagulants.. Hospital practice (1995), 42 ((5)): (108-125). [PMID:25485923]
75. Dirk Einecke. (2015-01-23) [Fewer strokes, lower mortality. Large general practice studies confirm good safety profile of dabigatran].. MMW Fortschritte der Medizin, 156 ((21-22)): (28-28). [PMID:25608388]
76. Susann Hasler. (2015-01-30) [Dabigatran and risk of bleeding].. Praxis, 104 ((3)): (157-158). [PMID:25626386]
77. Li Feng,Yanjun Xu,Yunpeng Zhang,Zeguo Sun,Junwei Han,Chunlong Zhang,Haixiu Yang,Desi Shang,Fei Su,Xinrui Shi,Shang Li,Chunquan Li,Xia Li. (2015-10-17) Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.. Oncotarget, 6 ((36)): (39151-39164). [PMID:26472186]
78. L O Melkonian,G E Avetisova,A A Ambartsumian,A Kh Chakhalian,A S Sagian. (2013-06-26) [Regulation of key enzymes of L-alanine biosynthesis by Brevibacterium flavum producer strains].. Prikladnaia biokhimiia i mikrobiologiia, 49 ((2)): (144-148). [PMID:23795472]
79. Syed Habibullah Kamran,Syeda Maria Muzammil,Ayeesha Kamran Kamal. (2013-07-20) What are the new therapeutic alternatives to warfarin in atrial fibrillation?. JPMA. The Journal of the Pakistan Medical Association, 63 ((1)): (129-130). [PMID:23865151]
80. Khaled Abass,Petri Reponen,Sampo Mattila,Arja Rautio,Olavi Pelkonen. (2013-09-11) Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic models.. Toxicology letters, 224 ((2)): (300-309). [PMID:24016712]
81. K Nordengen,C Morland,B S Slusher,V Gundersen. (2019-09-11) Dendritic Localization and Exocytosis of NAAG in the Rat Hippocampus.. Cerebral cortex (New York, N.Y. : 1991), 30 ((3)): (1422-1435). [PMID:31504271]
82. . (2014-07-22) Treatment of atrial fibrillation.. The Medical letter on drugs and therapeutics, 56 ((1446)): (53-58). [PMID:25046325]
83. Zelai Li, Maohong Fan, Ge Gao, Wufeng Jiang, Xiaoshan Li, Cong Luo, Liqi Zhang, Fan Wu. (2024) Potassium β–alanine – A promising agent for reducing carbon capture cost via electrochemically mediated amine regeneration. SEPARATION AND PURIFICATION TECHNOLOGY, 334 (125984). [PMID:]
84. Wei Hu, Jingchun Huang, Junwen Wang, Di Xie, Zhenqi Wang, Yu Qiao, Minghou Xu. (2024) Benign-by-design N-doped activated carbon from wasted aqueous assisted hydrochar of leftover rice for efficient H2S removal. FUEL, 358 (31): (130233). [PMID:10734105]
85. Ziyang Huang, Mingyang Guan, Ziting Bao, Fengyi Dong, Xiaolin Cui, Guozhen Liu. (2023) Ligand Mediation for Tunable and Oxide Suppressed Surface Gold-Decorated Liquid Metal Nanoparticles. Small, (2306652). [PMID:37806762]
86. Wenting Li, Hanjie Zhang, Sijie Huang, Jingyi Xu, Liping Liu, Junshan Li, Jianfang Jing, Yongfa Zhu. (2024) Electron-enriched supramolecular PDI-SiO2 promoting PDS activation for enhanced photocatalytic advanced oxidation. APPLIED CATALYSIS B-ENVIRONMENTAL, 340 (19): (123262). [PMID:17956732]
87. Rong Ji, Yuming Dong, Hui Zhao, Chengsi Pan, Guangli Wang, Yongfa Zhu, Junshan Li. (2023) Z-scheme cobalt-iron oxide/perylene diimide supermolecule heterojunction for high-efficiency ciprofloxacin removal in a photocatalysis-self-Fenton system. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 648 (623). [PMID:37321081]
88. Hui Xu, Chaohua Peng, Long Xia, Zhongxi Miao, Siyuan He, Cheng Chi, Weiang Luo, Guorong Chen, Birong Zeng, Shuchuan Wang, Lizong Dai. (2023) A Novel Anderson-Type POMs-Based Hybrids Flame Retardant for Reducing Smoke Release and Toxicity of Epoxy Resins. MACROMOLECULAR RAPID COMMUNICATIONS, 44 (17): (2300162). [PMID:37114515]
89. Kaiyang Shi, Man Zhou, Fulin Wang, Xiangwei Li, Weiya Huang, Kangqiang Lu, Kai Yang, Changlin Yu. (2023) Perylene diimide/iron phthalocyanine Z-scheme heterojunction with strong interfacial charge transfer through π-π interaction: Efficient photocatalytic degradation of tetracycline hydrochloride. CHEMOSPHERE, 329 (138617). [PMID:37037355]
90. Ziyang Lu, Bing Li, Xiaodie Zhu, Yangrui Xu, Jutao Zhang, Guosheng Zhou, Binghui Wei, Xinlin Liu, Jinyu Chu, Chundu Wu. (2023) IM-PDI/ZFO S-scheme heterojunction assembled by mutual magnetic attraction towards enhancing selective photodegradation ability. INORGANIC CHEMISTRY COMMUNICATIONS, 152 (110716). [PMID:]
91. Hai-Bin Qin, Jun-Ping Zhou, Bo Zhang, Zhi-Qiang Liu, Yu-Guo Zheng. (2022) Combing with redox regulation via quorum-sensing system and fermentation strategies for improving D-pantothenic acid production. PROCESS BIOCHEMISTRY, 121 (681). [PMID:]
92. Ge Gao, Xiaoshan Li, Wufeng Jiang, Zhenghong Zhao, Yongqing Xu, Fan Wu, Cong Luo, Liqi Zhang. (2022) Improved quasi-cycle capacity method based on microcalorimetry strategy for the fast screening of amino acid salt absorbents for CO2 capture. SEPARATION AND PURIFICATION TECHNOLOGY, 289 (120767). [PMID:]
93. Yangrui Xu, Xiaodie Zhu, Huan Yan, Panpan Wang, Minshan Song, Changchang Ma, Ziran Chen, Jinyu Chu, Xinlin Liu, Ziyang Lu. (2022) Hydrochloric acid-mediated synthesis of ZnFe2O4 small particle decorated one-dimensional Perylene Diimide S-scheme heterojunction with excellent photocatalytic ability. CHINESE JOURNAL OF CATALYSIS, 43 (1111). [PMID:]
94. Haoyi Wang, Ye Zhou, Jinnan Wang, Aimin Li, Philippe François-Xavier Corvini. (2022) BiOBr/ Bi4O5Br2/PDI constructed for visible-light degradation of endocrine disrupting chemicals: Synergistic effects of bi-heterojunction and oxygen evolution. CHEMICAL ENGINEERING JOURNAL, 433 (133622). [PMID:]
95. Wenlong Zhang, Jincheng Mao, Zhenfu Jia, Xiaojiang Yang, Peng Zhang, Xiaodong Su, Chengyu Zhou, Dan Bao, Wenbi Zeng. (2021) Design of a salt-tolerant Gemini viscoelastic surfactant and the study of construction of wormlike micelle structure in high-salinity aqueous environment. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 631 (127653). [PMID:]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.